Markus Pfirrmann
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 62
- Chronic Myeloid Leukemia Treatments 59
- Acute Myeloid Leukemia Research 7
- Genetics 44
- Chronic Lymphocytic Leukemia Research 35
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Diabetes and associated disorders 3
- Co-authors
- Joerg Hasford (36 shared papers)Rüdiger Hehlmann (29 shared papers)Susanne Saußele (30 shared papers)Juan Luis Steegmann (4 shared papers)Michele Baccarani (11 shared papers)Michele Baccarani (1 shared paper)N. C. Allan (1 shared paper)G. Alimena (1 shared paper)
- Journals
- Blood (23 papers)Leukemia (14 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Journal of Clinical Oncology (2 papers)Seminars in Hematology (2 papers)
- Partner nations
- GermanyNetherlandsSweden
In The Last Decade
Markus Pfirrmann
68 papers receiving 2.5k citations
Markus Pfirrmann's Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 2.0k
- Genetics 1.4k
- Rheumatology 795
- Critical Care and Intensive Care Medicine 53
- Pathology and Forensic Medicine 199
Countries citing papers authored by Markus Pfirrmann
This map shows the geographic impact of Markus Pfirrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Pfirrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Pfirrmann more than expected).
Fields of papers citing papers by Markus Pfirrmann
This network shows the impact of papers produced by Markus Pfirrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Pfirrmann. The network helps show where Markus Pfirrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Pfirrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group Hit paper breakdown → | 1998 | 522 |
| 2 | 2011 | 294 | |
| 3 | 2011 | 219 | |
| 4 | 2015 | 183 | |
| 5 | 2015 | 128 | |
| 6 | 2008 | 110 | |
| 7 | 2019 | 87 | |
| 8 | 2018 | 77 | |
| 9 | 2009 | 69 | |
| 10 | 1999 | 59 | |
| 11 | 2005 | 55 | |
| 12 | 2007 | 46 | |
| 13 | 2011 | 45 | |
| 14 | 2013 | 43 | |
| 15 | 2003 | 42 | |
| 16 | 2016 | 35 | |
| 17 | 2003 | 35 | |
| 18 | 2011 | 33 | |
| 19 | 2017 | 31 | |
| 20 | 2021 | 27 |
About Markus Pfirrmann
Markus Pfirrmann is a scholar working on Hematology, Genetics, Rheumatology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 74 papers that have together received 2.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (59 papers), Chronic Lymphocytic Leukemia Research (35 papers), Eosinophilic Disorders and Syndromes (20 papers), Lymphoma Diagnosis and Treatment (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (7 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (1.4k citations), Rheumatology (795 citations), Critical Care and Intensive Care Medicine (53 citations) and Pathology and Forensic Medicine (199 citations). Markus Pfirrmann has collaborated with scholars based in Germany, Netherlands and Sweden. Frequent co-authors include Joerg Hasford, Rüdiger Hehlmann, Susanne Saußele, Juan Luis Steegmann, Michele Baccarani, Michele Baccarani, N. C. Allan, G. Alimena, Hassan Ansari and Verena Hoffmann. Their work appears in journals such as Blood, Leukemia, Journal of Cancer Research and Clinical Oncology, Journal of Clinical Oncology and Seminars in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.